Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,152,500
+$1,096,403 QoQ
Shares Held
250,000
+18.3% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#113
of 515 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
40,988 | $6,908,117 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
250,000 | $6,152,500 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
500,000 | $4,915,000 | |
| 4 | LQDA |
Liquidia Corp
|
45,233 | $3,606,427 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
97,363 | $3,375,575 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,675 | $1,991,225 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
15,000 | $1,664,100 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,500 | $479,625 |
All Filings in ELAN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,152,500 | 250,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,056,097 | 211,287 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,330,965 | 323,949 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $366,850 | 18,215 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $544,767 | 38,149 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $487,788 | 46,456 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $429,844 | 35,495 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $208,201 | 14,173 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $490,518 | 33,993 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $211,460 | 12,989 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $364,498 | 24,463 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $141,770 | 12,613 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,378,470 | 137,025 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $392,102 | 41,713 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $587,684 | 48,092 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,534,595 | 123,658 | Shares | Sole | 2023-01-18 | |
| 2022-06-30 | $1,798,638 | 91,627 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $506,641 | 19,419 | Shares | Sole | 2022-06-02 | |
| 2021-12-31 | $811,980 | 28,611 | Shares | Sole | 2022-05-03 | |
| 2021-06-30 | $303,364 | 8,745 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $217,782 | 7,395 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,621,492 | 52,869 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $2,881,794 | 128,709 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||